| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
13,640,000 |
| Market
Cap: |
10.78(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.79 - $0.79 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Business Services |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sonnet BioTherapeutics Holdings is a clinical-stage biopharmaceutical company with a proprietary technology for developing biologic medicines it refers to as FHAB (Fully Human Albumin Binding). Co. has a pipeline of therapeutic compounds focused primarily on oncology indications of unmet medical need, including SON-080, a low-dose formulation of Interleukin 6 which is in development for Chemotherapy Induced Peripheral Neuropathy; SON-1010, which is being developed for solid tumor indications, including non-small cell lung cancer and head and neck cancer, as well as for antiviral applications; and SON-1210, which is being developed for solid tumor indications, including colorectal cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
479,855 |
539,855 |
| Total Buy Value |
$0 |
$0 |
$106,550 |
$141,650 |
| Total People Bought |
0 |
0 |
5 |
5 |
| Total Buy Transactions |
0 |
0 |
6 |
7 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pruitt Michael |
CEO, Chairman |
• • – |
2016-08-22 |
4 |
B |
$0.39 |
$390 |
I/I |
1,000 |
4,500 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2016-08-15 |
4 |
B |
$0.43 |
$429 |
I/I |
1,000 |
3,500 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2016-07-20 |
4 |
B |
$0.45 |
$224 |
I/I |
500 |
2,500 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2016-07-05 |
4 |
B |
$0.42 |
$420 |
D/D |
1,000 |
172,251 |
2.73 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2016-07-05 |
4 |
B |
$0.43 |
$432 |
I/I |
1,000 |
2,000 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2016-06-15 |
4 |
B |
$0.47 |
$235 |
I/I |
500 |
1,000 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2016-06-06 |
4 |
B |
$0.50 |
$251 |
I/I |
500 |
500 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2016-05-20 |
4 |
B |
$0.57 |
$1,140 |
D/D |
2,000 |
171,251 |
2.73 |
- |
|
| Moskowitz Paul I |
Director |
– • – |
2015-03-19 |
4 |
A |
$2.69 |
$13,450 |
D/D |
5,000 |
18,100 |
|
- |
|
| Carroll Mike |
Director |
– • – |
2015-03-19 |
4 |
A |
$2.69 |
$2,690 |
D/D |
1,000 |
16,500 |
|
- |
|
| Johnson Keith J |
Director |
– • – |
2014-12-31 |
4 |
A |
$1.73 |
$31,716 |
D/D |
18,333 |
19,333 |
|
- |
|
| Moskowitz Paul I |
Director |
– • – |
2014-12-31 |
4 |
A |
$1.73 |
$17,300 |
D/D |
10,000 |
13,100 |
|
- |
|
| Adams Richard |
President, ARB * |
– – – |
2014-12-31 |
4 |
A |
$1.73 |
$25,000 |
D/D |
14,451 |
22,451 |
|
- |
|
| Carroll Mike |
Director |
– • – |
2014-12-31 |
4 |
A |
$1.73 |
$17,300 |
D/D |
10,000 |
15,500 |
|
- |
|
| Page Russell Jacob |
Director |
– • – |
2014-12-31 |
4 |
A |
$1.73 |
$11,534 |
D/D |
6,667 |
7,667 |
|
- |
|
| Smith Darren Howard |
CFO of S. African Subsidiary |
• – – |
2014-12-24 |
4 |
B |
$1.50 |
$653 |
D/D |
435 |
811 |
2.66 |
- |
|
| Pruitt Michael |
CEO/President |
• • – |
2014-05-28 |
4 |
B |
$2.04 |
$612 |
I/I |
300 |
35,710 |
2.58 |
- |
|
| Roberson Mark Daniel |
Chief Operating OfficerOfficer |
• – – |
2014-05-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,663 |
|
- |
|
168 Records found
|
|
Page 7 of 7 |
|
|
